-
Mashup Score: 3Gaps in care delivery for patients with heart failure: A qualitative study of patients with multiple readmissions - 2 month(s) ago
Background Despite significant advances in the management of patients with heart failure with preserved and reduced ejection fraction (HFpEF and HFrEF), readmission rates remain high. Objectives I…
Categories: General Medicine NewsTweet
-
Mashup Score: 30JACC | Priorities for Evidence Generation - 2 month(s) ago
In clinical practice, we frequently encounter critical questions for which we lack solid evidence. Whether on rounds or in the clinic, we often make decisions under uncertainty, wondering, “Why don’t we have data that answers this question?” To bridge these gaps, we at JACC are partnering with the FDA to surface these key questions. We want to hear directly from you: What pressing questions do you face regarding the use of FDA-regulated products—drugs, biologics, devices, food, and tobacco—that impact
Source: www.jacc.orgCategories: General Medicine NewsTweet-
Clinicians' voices are often ignored when prioritizing the most important questions in research. @JACCJournals & @hmkyale and @US_FDA & @DrCaliff_FDA are changing that. We need your ideas! CC @drjohnm @JReinerMD @DavidLBrownMD @mvaduganathan & others 👉https://t.co/rnY3qwrjFg https://t.co/e8Cel7rDeb
-
-
Mashup Score: 30JACC | Priorities for Evidence Generation - 4 month(s) ago
In clinical practice, we frequently encounter critical questions for which we lack solid evidence. Whether on rounds or in the clinic, we often make decisions under uncertainty, wondering, “Why don’t we have data that answers this question?” To bridge these gaps, we at JACC are partnering with the FDA to surface these key questions. We want to hear directly from you: What pressing questions do you face regarding the use of FDA-regulated products—drugs, biologics, devices, food, and tobacco—that impact
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet-
Clinicians' voices are often ignored when prioritizing the most important questions in research. @JACCJournals & @hmkyale and @US_FDA & @DrCaliff_FDA are changing that. We need your ideas! CC @drjohnm @JReinerMD @DavidLBrownMD @mvaduganathan & others 👉https://t.co/rnY3qwrjFg https://t.co/e8Cel7rDeb
-
-
Mashup Score: 29JACC | Priorities for Evidence Generation - 5 month(s) ago
In clinical practice, we frequently encounter critical questions for which we lack solid evidence. Whether on rounds or in the clinic, we often make decisions under uncertainty, wondering, “Why don’t we have data that answers this question?” To bridge these gaps, we at JACC are partnering with the FDA to surface these key questions. We want to hear directly from you: What pressing questions do you face regarding the use of FDA-regulated products—drugs, biologics, devices, food, and tobacco—that impact
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet-
Clinicians' voices are often ignored when prioritizing the most important questions in research. @JACCJournals & @hmkyale and @US_FDA & @DrCaliff_FDA are changing that. We need your ideas! CC @drjohnm @JReinerMD @DavidLBrownMD @mvaduganathan & others 👉https://t.co/rnY3qwrjFg https://t.co/e8Cel7rDeb
-
-
Mashup Score: 4JACC | Priorities for Evidence Generation - 5 month(s) ago
In clinical practice, we frequently encounter critical questions for which we lack solid evidence. Whether on rounds or in the clinic, we often make decisions under uncertainty, wondering, “Why don’t we have data that answers this question?” To bridge these gaps, we at JACC are partnering with the FDA to surface these key questions. We want to hear directly from you: What pressing questions do you face regarding the use of FDA-regulated products—drugs, biologics, devices, food, and tobacco—that impact
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet-
Clinicians' voices are often ignored when prioritizing the most important questions in research. @JACCJournals & @hmkyale and @US_FDA & @DrCaliff_FDA are changing that. We need your ideas! CC @drjohnm @JReinerMD @DavidLBrownMD @mvaduganathan & others 👉https://t.co/rnY3qwrjFg https://t.co/e8Cel7rDeb
-
-
Mashup Score: 29JACC | Priorities for Evidence Generation - 6 month(s) ago
In clinical practice, we frequently encounter critical questions for which we lack solid evidence. Whether on rounds or in the clinic, we often make decisions under uncertainty, wondering, “Why don’t we have data that answers this question?” To bridge these gaps, we at JACC are partnering with the FDA to surface these key questions. We want to hear directly from you: What pressing questions do you face regarding the use of FDA-regulated products—drugs, biologics, devices, food, and tobacco—that impact
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet-
Clinicians' voices are often ignored when prioritizing the most important questions in research. @JACCJournals & @hmkyale and @US_FDA & @DrCaliff_FDA are changing that. We need your ideas! CC @drjohnm @JReinerMD @DavidLBrownMD @mvaduganathan & others 👉https://t.co/rnY3qwrjFg https://t.co/e8Cel7rDeb
-
-
Mashup Score: 24NIH-FDA Nutrition Regulatory Science Workshop - 6 month(s) ago
The goal of this joint NIH-FDA workshop is to highlight how nutrition science can generate evidence and data to inform food-related policy and regulatory decision making and to foster additional collaboration between NIH and FDA in supporting research that addresses priority nutrition research gaps.
Source: www.fda.govCategories: General Medicine News, CardiologistsTweet-
Diet related diseases are surging yet nutrition science needs to be improved. Thus @US_FDA and @NIH are collaborating for the first Nutrition Regulatory Science Workshop to devise the future of nutrition science and policy, focusing on ultraprocessed food. https://t.co/DrXtnXbPxv https://t.co/7mgEfNvxAK
-
-
Mashup Score: 29JACC | Priorities for Evidence Generation - 6 month(s) ago
In clinical practice, we frequently encounter critical questions for which we lack solid evidence. Whether on rounds or in the clinic, we often make decisions under uncertainty, wondering, “Why don’t we have data that answers this question?” To bridge these gaps, we at JACC are partnering with the FDA to surface these key questions. We want to hear directly from you: What pressing questions do you face regarding the use of FDA-regulated products—drugs, biologics, devices, food, and tobacco—that impact
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet-
Clinicians' voices are often ignored when prioritizing the most important questions in research. @JACCJournals & @hmkyale and @US_FDA & @DrCaliff_FDA are changing that. We need your ideas! CC @drjohnm @JReinerMD @DavidLBrownMD @mvaduganathan & others 👉https://t.co/rnY3qwrjFg https://t.co/e8Cel7rDeb
-
-
Mashup Score: 29JACC | Priorities for Evidence Generation - 6 month(s) ago
In clinical practice, we frequently encounter critical questions for which we lack solid evidence. Whether on rounds or in the clinic, we often make decisions under uncertainty, wondering, “Why don’t we have data that answers this question?” To bridge these gaps, we at JACC are partnering with the FDA to surface these key questions. We want to hear directly from you: What pressing questions do you face regarding the use of FDA-regulated products—drugs, biologics, devices, food, and tobacco—that impact
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet-
Clinicians' voices are often ignored when prioritizing the most important questions in research. @JACCJournals & @hmkyale and @US_FDA & @DrCaliff_FDA are changing that. We need your ideas! CC @drjohnm @JReinerMD @DavidLBrownMD @mvaduganathan & others 👉https://t.co/rnY3qwrjFg https://t.co/e8Cel7rDeb
-
-
Mashup Score: 2
This blog focuses on the potential of leveraging lifecycle management to address the unique challenges of generative AI in health care.
Source: www.fda.govCategories: General Medicine News, CardiologistsTweet-
4/5 Since AI is a unique technology highly sensitive to context, it is essential to adopt a life cycle approach that incorporates recurrent evaluation of the technology in the setting it is being used in. We provide more details here: https://t.co/dtHHTs1H2Q https://t.co/ns0c0P8hmw
-
No wonder I am excited about GenAI and agents systems bridging these gaps and allowing clinicians space to be present with their patients. Thanks to an all star team. Qualitative research is hard. No one better at it than @Zaralatif5. Read more 👇3/3 https://t.co/asjnmcqNSy